ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,852Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 1006

$675K Total Retail Price of All Prescriptions

Rank: 113 out of 1006

291 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 291 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 10,957 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 883 749 1 8
METOPROLOL TARTRATE 548 535 2 7
FUROSEMIDE 431 410 3 6
SIMVASTATIN 409 366 4 1
LISINOPRIL 393 379 5 3
MIRTAZAPINE 342 334 6 26
AMLODIPINE BESYLATE 335 319 7 4
TRAZODONE HCL 303 301 8 21
LEVOTHYROXINE SODIUM 285 271 9 2
SERTRALINE HCL 246 241 10 19
OMEPRAZOLE 217 194 11 9
METOPROLOL SUCCINATE 206 206 12 12
DONEPEZIL HCL 193 193 13 17
GABAPENTIN 189 159 14 20
ESCITALOPRAM OXALATE 185 179 15 27
LANTUS 184 160 16 43
ATORVASTATIN CALCIUM 179 176 17 5
CITALOPRAM HBR 172 172 18 24
DIGOXIN 165 163 19 52
CYMBALTA 160 143 20 41
TAMSULOSIN HCL 154 149 21 23
NAMENDA 148 148 22 34
METFORMIN HCL 129 115 23 10
POTASSIUM CHLORIDE 125 122 24 30
LEVETIRACETAM 110 101 25 72
ATENOLOL 109 84 26 13
TRAMADOL HCL 98 91 27 35
QUETIAPINE FUMARATE 98 98 27 45
CLOPIDOGREL 96 93 29 46
OLANZAPINE 95 84 30 68
RISPERIDONE 90 90 31 40
IPRATROPIUM-ALBUTEROL 86 84 32 73
CARVEDILOL 85 85 33 36
RAMIPRIL 80 67 34 79
PLAVIX 80 80 34 61
PREDNISONE 80 77 34 33
HYDROCHLOROTHIAZIDE 78 78 37 11
FENTANYL 72 67 S2 38 74
DIVALPROEX SODIUM 71 71 39 53
NOVOLOG 69 50 40 94
BACLOFEN 66 53 41 95
FLUOXETINE HCL 65 62 42 85
CARBIDOPA-LEVODOPA 65 65 42 80
SEROQUEL 63 63 44 97
LEVOFLOXACIN 61 56 45 96
ZOLPIDEM TARTRATE 59 55 46 14
NIASPAN 59 35 46 212
DIOVAN 57 55 48 16
LIDODERM 55 49 49 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.